Floatz logo

Clic-2201

High Grade B-Cell Lymphoma

British Columbia Cancer AgencyPhase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

89 Active assets in the High Grade B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Ifosfamide
University of California, Davis
Phase 3BB
ETOPOSIDE
University of Washington
Phase 3BB
PREDNISONE TABLETS
National Cancer Institute (NCI)
Phase 3BB
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 2/3BB
Inno-206
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

Clic-2201 is also rated in:

B-cell acute lymphoblastic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
primary mediastinal large B-cell lymphomaDormant
CC
Indicative ·
41 / 100
View asset →
non-Hodgkin lymphomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →